Artificial Kidney Market (2023 - 2033)
Artificial Kidney Market Analysis by Wearable and Implantable Artificial Kidneys for Hospitals, Specialty Clinics, and Ambulatory Surgical Centers from 2023 to 2033
Core Findings
FREE CustomizationArtificial Kidney Market Growth Outlook for 2023 to 2033
The global artificial kidney market is valued at US$ 1.5 billion in 2023 and is predicted to surge ahead at a CAGR of 13% to reach a market size of US$ 5.3 billion by the end of 2033.
A hemodialyzer, also referred to as an artificial kidney, is a machine used to filter a patient's blood with kidney impairment. This is a technology that can mimic the function of an actual kidney and possibly do away with the need for dialysis. For patients whose kidneys have been severely damaged and are unable of performing their normal functions, this artificial dialysis can offer continuous blood filtration. It improves patient quality of life and helps to minimize chronic renal disease.
Silicon nano filters are used in artificial kidney implants to filter out water, salts, poisons, and other tiny compounds. The two primary factors projected to drive the growth of the global artificial kidney market are the rising number of patients with kidney-related disorders around the world and the limited supply of kidney donors.
- According to the National Center of Biotechnology Information, 10% of the world's population is living with chronic kidney disease (CKD), which affects 1 in 4 men and 1 in 5 women between the ages of 65 and 74.
The two types of artificial kidneys are wearable artificial kidneys and implantable artificial kidneys. A portable medical gadget known as a wearable artificial kidney enables patients to benefit from home dialysis to do their daily tasks.
This gadget helps to enhance the quality of life of individuals with end-stage renal disease by minimizing their hospital stays and improving physiological aspects by lowering blood pressure. Furthermore, it reduces salt retention as well as the risk of vascular disease and stroke. Also, it is less expensive than other medicines offered to patients with renal failure.
Peritoneal dialysis is a method of treatment that may be performed at home and requires the least amount of technical support. By administering tiny tidal infusions of dialysate, a modified autonomous wearable artificial kidney (AWAK) automates peritoneal dialysis.
Development of an implantable artificial kidney (IAK) is still in progress. In this method, the patient would undergo surgery to get a tiny artificial kidney. The cardiovascular system perfuses the kidney, much like naturally occurring kidneys, without the usage of pumps or batteries.
The silicon implantable kidney cartridge has extremely pore-filled microslits, which produce ultrafiltrate that drains into the patient's bladder. Thus, the introduction of advanced implantable artificial kidneys is expected to open up several opportunities for market players.
=
| Report Attributes | Details |
|---|---|
| Artificial Kidney Market Size (2023E) | US$ 1.5 Billion |
| Forecasted Market Value (2033F) | US$ 5.3 Billion |
| Global Market Growth Rate (2023 to 2033) | 13% CAGR |
| Leading Regional Market | North America |
| Key Companies Profiled | Kawasumi Laboratories Inc.;Nanodialysis B.V.;Fresenius SE & Co KGaA;Baxter;Asahi Kasei Medical Co., Ltd.;Medtronic;DaVita Inc;Merit Medical Systems;Nipro Medical Corporation;Nikkiso Co Ltd;B. Braun Melsungen AG;AWAK Technologies |
Which Dynamics are Expected to Generate Lucrative Opportunities in the Artificial Kidney Market?
“Developments in Production of Advanced Portable Bio-artificial Kidneys”
Exciting new advances are occurring in the field of artificial kidneys, often in parallel and concerning one another. Most of these are still in the testing stages and are not yet available for clinical usage, except for some of the advanced dialysis applications.
End-stage renal disease (ESRD) management has undergone a paradigm shift from ‘disease-centered’ to ‘patient-centered’, with patient preferences and quality of life playing a crucial part in decision-making. A device that can be installed inside the body and performs normal renal function indefinitely would be the pinnacle of artificial kidney technology.
- According to PubMed, The Kidney Project, a partnership between Dr Shuvo Roy's team at the University of California, San Francisco, and Dr William Fissell's team at Vanderbilt University, intends to accomplish the same. Their implantable bio-artificial kidney (iBAK) uses a micro-electromechanical system to reduce the size of the renal assist device (RAD) and combines silicon nanotechnology and tissue engineering.
“Rising Prevalence of Kidney-related Diseases Worldwide”
Increasing cases of kidney disorders are expected to boost demand for artificial kidneys in the coming 10 years.
- The National Kidney Foundation (NKD) estimates that 10% of the world's population is living with CKD and that millions of people die from this ailment each year as they cannot afford treatment costs.
- According to NKD projections, the elderly population is more likely to experience renal issues, particularly in developing countries such as China and India.
- According to the same source, patients who require dialysis or a kidney transplant to survive are expected to rise at a pace of 5% to 7% annually.
Diabetes is the most prevalent cause of end-stage kidney disease (ESRD), and about one-third of people with diabetes develop chronic kidney disorders. High blood pressure is the main cause of hypertension, and it also considerably raises the risk of ESRD.
- According to World Health Organization (WHO), globally, 1.28 billion individuals between the ages of 30 and 79 are living with hypertension, with a majority (two-thirds) living in middle-income and low-income countries.
- Adults with hypertension in less than half (42%) of cases receive proper treatment.
What Could Hamper the Profitability of Artificial Kidney Manufacturers?
“High Costs of Artificial Kidney Implants”
Several companies in the artificial kidney market are investing heavily in R&D activities to develop advanced artificial kidney machines. Thus, technological advancements call for high investments, which further increases the price of finished products (improved artificial kidney implants).
The target patient population in developing regions cannot afford expensive artificial kidneys due to their lower income capabilities. This further is expected to hamper sales of artificial kidneys to some extent in the coming 10 years.
“Obtaining Regulatory Approval for New Devices Can Be Time-consuming & Costly”
Strict product approval regulations are expected to slower sales of artificial kidneys during the forecast period. This can be due to the longer time required for the approval of finished products as they should meet all requirements prescribed by respective authorities.
What is Expected to Help New Entrants Achieve Significant Market Progress?
“Start-ups Can Focus on Introduction of Advanced Technologies in Artificial Kidney Implants”
Growing demand for artificial kidneys presents a significant opportunity for new manufacturers to enter the market. Increasing prevalence of CKD and the growing need for renal replacement therapies show that there is a constant demand for new and innovative devices that can meet the evolving needs of patients.
New manufacturers can be benefitted from technological advancements such as 3D printing, nanotechnology, and artificial intelligence, which may help them to develop more efficient and effective artificial kidneys. These technologies can enable manufacturers to produce devices that are smaller, more portable, and have a longer lifespan, which can improve patient outcomes and reduce the overall cost of care.
Moreover, new manufacturers can focus on developing devices that cater to specific patient populations, such as pediatric or elderly patients, who have unique needs that are not adequately addressed by current devices in the market. By developing specialized devices, new players can differentiate themselves from established players and carve out a niche in the market.
Country-wise Analysis
What is Aiding United States’ Manufacturers of Artificial Kidneys in Earning More?
“Rapid Ongoing Advancements in Artificial Kidneys Due to Presence of Key Market Players”
Increasing prevalence of chronic kidney disorders, the presence of well-established healthcare facilities, the existence of major companies of artificial kidneys, the high spending power of the population on healthcare, and technologically enhanced diagnostic tests are the main factors propelling the growth of the United States artificial kidney market.
- According to the American Kidney Fund study released in February 2022, 92,000 Americans were waiting for kidney transplants, while an estimated 37 million Americans were living with renal disease.
- The Kidney Project's bio-artificial implantable kidney, which aims to discharge patients with kidney disease from waiting lists for transplants and dialysis machines, made another significant advancement towards becoming a reality by winning a US$ 650,000 reward from KidneyX in 2021 for its first-ever demonstration of a functional prototype of its artificial implantable kidney.
- Founded to ‘accelerate innovation in the prevention, diagnosis, and treatment of kidney illnesses’, KidneyX is a public-private collaboration between the United States Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN).
How is Demand for Artificial Kidneys Expected to Evolve in China?
“Chronic Kidney Disorder - Severe National Health Problem”
One of the key causes driving artificial kidney sales in China is the rising cases of kidney diseases. CKD is a serious health issue in China.
- Chronic kidney disease (CKD) is considered a serious public health issue in China that is characterized by its high incidence, high death rate, and numerous comorbidities, according to a report that was released by NCBI in October 2022.
- The National Institutes of Health (NIH) report from June 2021 found that renal disease treated with dialysis is more common in China than it was in 2000 and is projected to keep on increasing through 2025.
- Several individuals in China are expected to require artificial kidneys due to the rising prevalence of chronic renal disease and end-stage chronic kidney disease, according to the British Medical Journal (BMJ), 2021.
Will Germany Be a Profitable Market for Suppliers of Artificial Kidney Implants?
“Increasing Cases of Kidney Transplants Encouraging Market Players to Introduce Advanced Solutions”
Artificial kidneys, also known as hemodialysis machines, are in high demand in Germany due to the rising cases of kidney-related disorders and rapid technological developments in the field of artificial kidneys.
- According to the German Society of Nephrology, over 80,000 people in Germany are currently undergoing hemodialysis treatment, and this number is expected to continue to rise in the coming years.
Demand for artificial kidneys in Germany is also driven by the country's ageing population. As people get older, they become more susceptible to chronic kidney disease and may require hemodialysis treatment to manage their condition. Additionally, lifestyle factors such as obesity and diabetes can also contribute to the development of chronic kidney disease, which further are expected to fuel sales of artificial kidneys.
To meet the growing demand for hemodialysis machines in Germany, there has been significant investment in research and development to improve the effectiveness and efficiency of these devices. New technologies such as portable hemodialysis machines and wearable devices are being developed by market players to make treatment more accessible and convenient for patients.
- According to the Deutsches Referenzzentrum fur Ethik den Biowissenschaften published in October 2022, the total number of kidney transplants in Germany in 2021 reached 1,994 compared to 1,909 in the previous year. Thus, the growing cases of kidney transplants are expected to boost demand for artificial kidneys during the forecast period.
Category-wise Analysis
Why are Surgeries of Artificial Kidney Implants Widely Performed in Hospitals?
“Presence of Advanced Healthcare Technologies & Medical Experts”
Artificial kidneys are highly demanded in hospitals to treat target patients. Individuals with kidney disorders prefer hospitals as the prime choice for treatment procedures due to the presence of skilled doctors and advanced healthcare infrastructure.
Hospitals are the principal facilities for any surgical operations. Thus, sales of artificial kidneys are expected to increase during the forecast period due to the complete care offered in hospital settings.
Competitive Landscape
Key players in the artificial kidney market are focused on advancing artificial kidney implants, and along with that, they are taking initiatives to expand their business by collaborating with local market players. Some of the leading companies are focusing on acquisitions to increase their product folio and boost their market position.
Key Segments of Artificial Kidney Industry Research
-
By Type :
- Wearable Artificial Kidneys
- Implantable Artificial Kidneys
-
By Dialysis :
- Hemodialysis
- Peritoneal Dialysis
- Combination
-
By Application :
- Adults
- Pediatrics
-
By End User :
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033)
- 6. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Type
- 6.1. Type Analysis
- 6.1.1. Wearable Artificial Kidneys
- 6.1.2. Implantable Artificial Kidneys
- 6.1. Type Analysis
- 7. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Dialysis
- 7.1. Dialysis Types
- 7.1.1. Hemodialysis
- 7.1.2. Peritoneal Dialysis
- 7.1.3. Combination
- 7.1. Dialysis Types
- 8. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Application
- 8.1. Application Types
- 8.1.1. Adults
- 8.1.2. Pediatrics
- 8.1. Application Types
- 9. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by End User
- 9.1. End User Categories
- 9.1.1. Hospitals
- 9.1.2. Specialty Clinics
- 9.1.3. Ambulatory Surgical Centers
- 9.1. End User Categories
- 10. Global Market Analysis (2018 to 2022) and Forecast (2023 to 2033), by Region
- 10.1. Regional Breakdown
- 10.1.1. North America
- 10.1.2. Europe
- 10.1.3. East Asia
- 10.1.4. South Asia
- 10.1.5. Latin America
- 10.1.6. Middle East & Africa (MEA)
- 10.1.7. Oceania
- 10.1. Regional Breakdown
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Kawasumi Laboratories Inc.
- 20.2. Nanodialysis B.V.
- 20.3. Fresenius SE & Co KGaA
- 20.4. Baxter
- 20.5. Asahi Kasei Medical Co., Ltd.
- 20.6. Medtronic
- 20.7. DaVita Inc
- 20.8. Merit Medical Systems
- 20.9. Nipro Medical Corporation
- 20.10. Nikkiso Co Ltd
- 20.11. B. Braun Melsungen AG
- 20.12. AWAK Technologies
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
List Of Table
Table 01: Global Market by Type, 2018 to 2033
Table 02: Global Market Value (US$ Mn), by Type, 2018 to 2033
Table 03: Global Market by Dialysis, 2018 to 2033
Table 04: Global Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 05: Global Market by Application, 2018 to 2033
Table 06: Global Market Value (US$ Mn), by Application, 2018 to 2033
Table 07: Global Market by End User, 2018 to 2033
Table 08: Global Market Value (US$ Mn), by End User, 2018 to 2033
Table 09: Global Market by Region, 2018 to 2033
Table 10: Global Market Value (US$ Mn), by Region, 2018 to 2033
Table 11: North America Market by Type, 2018 to 2033
Table 12: North America Market Value (US$ Mn), by Type, 2018 to 2033
Table 13: North America Market by Dialysis, 2018 to 2033
Table 14: North America Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 15: North America Market by Application, 2018 to 2033
Table 16: North America Market Value (US$ Mn), by Application, 2018 to 2033
Table 17: North America Market by End User, 2018 to 2033
Table 18: North America Market Value (US$ Mn), by End User, 2018 to 2033
Table 19: North America Market by Country, 2018 to 2033
Table 20: North America Market Value (US$ Mn), by Country, 2018 to 2033
Table 21: Europe Market by Type, 2018 to 2033
Table 22: Europe Market Value (US$ Mn), by Type, 2018 to 2033
Table 23: Europe Market by Dialysis, 2018 to 2033
Table 24: Europe Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 25: Europe Market by Application, 2018 to 2033
Table 26: Europe Market Value (US$ Mn), by Application, 2018 to 2033
Table 27: Europe Market by End User, 2018 to 2033
Table 28: Europe Market Value (US$ Mn), by End User, 2018 to 2033
Table 29: Europe Market by Country, 2018 to 2033
Table 30: Europe Market Value (US$ Mn), by Country, 2018 to 2033
Table 31: East Asia Market by Type, 2018 to 2033
Table 32: East Asia Market Value (US$ Mn), by Type, 2018 to 2033
Table 33: East Asia Market by Dialysis, 2018 to 2033
Table 34: East Asia Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 35: East Asia Market by Application, 2018 to 2033
Table 36: East Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 37: East Asia Market by End User, 2018 to 2033
Table 38: East Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 39: East Asia Market by Country, 2018 to 2033
Table 40: East Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 41: South Asia Market by Type, 2018 to 2033
Table 42: South Asia Market Value (US$ Mn), by Type, 2018 to 2033
Table 43: South Asia Market by Dialysis, 2018 to 2033
Table 44: South Asia Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 45: South Asia Market by Application, 2018 to 2033
Table 46: South Asia Market Value (US$ Mn), by Application, 2018 to 2033
Table 47: South Asia Market by End User, 2018 to 2033
Table 48: South Asia Market Value (US$ Mn), by End User, 2018 to 2033
Table 49: South Asia Market by Country, 2018 to 2033
Table 50: South Asia Market Value (US$ Mn), by Country, 2018 to 2033
Table 51: Latin America Market by Type, 2018 to 2033
Table 52: Latin America Market Value (US$ Mn), by Type, 2018 to 2033
Table 53: Latin America Market by Dialysis, 2018 to 2033
Table 54: Latin America Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 55: Latin America Market by Application, 2018 to 2033
Table 56: Latin America Market Value (US$ Mn), by Application, 2018 to 2033
Table 57: Latin America Market by End User, 2018 to 2033
Table 58: Latin America Market Value (US$ Mn), by End User, 2018 to 2033
Table 59: Latin America Market by Country, 2018 to 2033
Table 60: Latin America Market Value (US$ Mn), by Country, 2018 to 2033
Table 61: Middle East and Africa Market by Type, 2018 to 2033
Table 62: Middle East and Africa Market Value (US$ Mn), by Type, 2018 to 2033
Table 63: Middle East and Africa Market by Dialysis, 2018 to 2033
Table 64: Middle East and Africa Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 65: Middle East and Africa Market by Application, 2018 to 2033
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2018 to 2033
Table 67: Middle East and Africa Market by End User, 2018 to 2033
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2018 to 2033
Table 69: Middle East and Africa Market by Country, 2018 to 2033
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2018 to 2033
Table 71: Oceania Market by Type, 2018 to 2033
Table 72: Oceania Market Value (US$ Mn), by Type, 2018 to 2033
Table 73: Oceania Market by Dialysis, 2018 to 2033
Table 74: Oceania Market Value (US$ Mn), by Dialysis, 2018 to 2033
Table 75: Oceania Market by Application, 2018 to 2033
Table 76: Oceania Market Value (US$ Mn), by Application, 2018 to 2033
Table 77: Oceania Market by End User, 2018 to 2033
Table 78: Oceania Market Value (US$ Mn), by End User, 2018 to 2033
Table 79: Oceania Market by Country, 2018 to 2033
Table 80: Oceania Market Value (US$ Mn), by Country, 2018 to 2033
List Of Figures
Fig 01: Global Market Value (US$) and Y-o-Y Growth, 2018 to 2033
Fig 02: Global Absolute $ Historical Market (2018 to 2022) and Absolute $ Opportunity (2023 to 2033), US$ Mn
Fig 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Fig 04: Global Market Incremental $ Opportunity (US$ Thousand), 2023 to 2033
Fig 05: Global Market Share, By Type &-; 2023 to 2033
Fig 06: Global Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 07: Global Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 08: Global Market Share, By Dialysis &-; 2023 to 2033
Fig 09: Global Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 10: Global Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 11: Global Market Share, By Application &-; 2023 to 2033
Fig 12: Global Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 13: Global Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 14: Global Market Share, By End User &-; 2023 to 2033
Fig 15: Global Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 16: Global Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 17: Global Market Share, by Region &-; 2023 to 2033
Fig 18: Global Market Y-o-Y Growth Projections, by Region &-; 2023 to 2033
Fig 19: Global Market Attractiveness Index, by Region &-; 2023 to 2033
Fig 20: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 21: North America Market Share, By Type &-; 2023 to 2033
Fig 22: North America Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 23: North America Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 24: North America Market Share, By Dialysis &-; 2023 to 2033
Fig 25: North America Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 26: North America Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 27: North America Market Share, By Application &-; 2023 to 2033
Fig 28: North America Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 29: North America Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 30: North America Market Share, By End User &-; 2023 to 2033
Fig 31: North America Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 32: North America Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 33: North America Market Share, By Country &-; 2023 to 2033
Fig 34: North America Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 35: North America Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 36: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 37: Europe Market Share, By Type &-; 2023 to 2033
Fig 38: Europe Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 39: Europe Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 40: Europe Market Share, By Dialysis &-; 2023 to 2033
Fig 41: Europe Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 42: Europe Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 43: Europe Market Share, By Application &-; 2023 to 2033
Fig 44: Europe Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 45: Europe Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 46: Europe Market Share, By End User &-; 2023 to 2033
Fig 47: Europe Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 48: Europe Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 49: Europe Market Share, By Country &-; 2023 to 2033
Fig 50: Europe Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 51: Europe Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 52: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 53: East Asia Market Share, By Type &-; 2023 to 2033
Fig 54: East Asia Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 55: East Asia Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 56: East Asia Market Share, By Dialysis &-; 2023 to 2033
Fig 57: East Asia Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 58: East Asia Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 59: East Asia Market Share, By Application &-; 2023 to 2033
Fig 60: East Asia Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 61: East Asia Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 62: East Asia Market Share, By End User &-; 2023 to 2033
Fig 63: East Asia Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 64: East Asia Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 65: East Asia Market Share, By Country &-; 2023 to 2033
Fig 66: East Asia Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 67: East Asia Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 68: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 69: South Asia Market Share, By Type &-; 2023 to 2033
Fig 70: South Asia Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 71: South Asia Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 72: South Asia Market Share, By Dialysis &-; 2023 to 2033
Fig 73: South Asia Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 74: South Asia Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 75: South Asia Market Share, By Application &-; 2023 to 2033
Fig 76: South Asia Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 77: South Asia Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 78: South Asia Market Share, By End User &-; 2023 to 2033
Fig 78: South Asia Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 80: South Asia Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 81: South Asia Market Share, By Country &-; 2023 to 2033
Fig 82: South Asia Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 83: South Asia Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 84: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 85: Latin America Market Share, By Type &-; 2023 to 2033
Fig 86: Latin America Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 87: Latin America Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 88: Latin America Market Share, By Dialysis &-; 2023 to 2033
Fig 89: Latin America Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 90: Latin America Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 91: Latin America Market Share, By Application &-; 2023 to 2033
Fig 92: Latin America Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 93: Latin America Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 94: Latin America Market Share, By End User &-; 2023 to 2033
Fig 95: Latin America Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 96: Latin America Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 97: Latin America Market Share, By Country &-; 2023 to 2033
Fig 98: Latin America Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 99: Latin America Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 100: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 101: MEA Market Share, By Type &-; 2023 to 2033
Fig 102: MEA Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 103: MEA Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 104: MEA Market Share, By Dialysis &-; 2023 to 2033
Fig 105: MEA Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 106: MEA Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 107: MEA Market Share, By Application &-; 2023 to 2033
Fig 108: MEA Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 109: MEA Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 110: MEA Market Share, By End User &-; 2023 to 2033
Fig 111: MEA Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 112: MEA Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 113: MEA Market Share, By Country &-; 2023 to 2033
Fig 114: MEA Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 115: MEA Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 116: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 117: Oceania Market Share, By Type &-; 2023 to 2033
Fig 118: Oceania Market Y-o-Y Growth Projections, By Type &-; 2023 to 2033
Fig 119: Oceania Market Attractiveness Index, By Type &-; 2023 to 2033
Fig 120: Oceania Market Share, By Dialysis &-; 2023 to 2033
Fig 121: Oceania Market Y-o-Y Growth Projections, By Dialysis &-; 2023 to 2033
Fig 122: Oceania Market Attractiveness Index, By Dialysis &-; 2023 to 2033
Fig 123: Oceania Market Share, By Application &-; 2023 to 2033
Fig 124: Oceania Market Y-o-Y Growth Projections, By Application &-; 2023 to 2033
Fig 125: Oceania Market Attractiveness Index, By Application &-; 2023 to 2033
Fig 126: Oceania Market Share, By End User &-; 2023 to 2033
Fig 127: Oceania Market Y-o-Y Growth Projections, By End User &-; 2023 to 2033
Fig 128: Oceania Market Attractiveness Index, By End User &-; 2023 to 2033
Fig 129: Oceania Market Share, By Country &-; 2023 to 2033
Fig 130: Oceania Market Y-o-Y Growth Projections, By Country &-; 2023 to 2033
Fig 131: Oceania Market Attractiveness Index, By Country &-; 2023 to 2033
Fig 132: United States Market share by Type, 2022
Fig 133: United States Market share by Dialysis, 2022
Fig 134: United States Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 135: United States Market Share by End User, 2022
Fig 136: Canada Market share by Type, 2022
Fig 137: Canada Market share by Dialysis, 2022
Fig 138: Canada Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 139: Canada Market Share by End User, 2022
Fig 140: Germany Market share by Type, 2022
Fig 141: Germany Market share by Dialysis, 2022
Fig 142: Germany Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 143: Germany Market Share by End User, 2022
Fig 144: United Kingdom Market share by Type, 2022
Fig 145: United Kingdom Market share by Dialysis, 2022
Fig 146: United Kingdom Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 147: United Kingdom Market Share by End User, 2022
Fig 148: France Market share by Type, 2022
Fig 149: France Market share by Dialysis, 2022
Fig 150: France Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 151: France Market Share by End User, 2022
Fig 152: Russia Market share by Type, 2022
Fig 153: Russia Market share by Dialysis, 2022
Fig 154: Russia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 155: Russia Market Share by End User, 2022
Fig 156: Spain Market share by Type, 2022
Fig 157: Spain Market share by Dialysis, 2022
Fig 158: Spain Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 159: Spain Market Share by End User, 2022
Fig 160: Italy Market share by Type, 2022
Fig 161: Italy Market share by Dialysis, 2022
Fig 162: Italy Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 163: Italy Market Share by End User, 2022
Fig 164: China Market share by Type, 2022
Fig 165: China Market share by Dialysis, 2022
Fig 166: China Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 167: China Market Share by End User, 2022
Fig 168: Japan Market share by Type, 2022
Fig 169: Japan Market share by Dialysis, 2022
Fig 170: Japan Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 171: Japan Market Share by End User, 2022
Fig 172: South Korea Market share by Type, 2022
Fig 173: South Korea Market share by Dialysis, 2022
Fig 174: South Korea Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 175: South Korea Market Share by End User, 2022
Fig 176: India Market share by Type, 2022
Fig 177: India Market share by Dialysis, 2022
Fig 178: India Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 179: India Market Share by End User, 2022
Fig 180: Singapore Market share by Type, 2022
Fig 181: Singapore Market share by Dialysis, 2022
Fig 182: Singapore Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 183: Singapore Market Share by End User, 2022
Fig 184: Indonesia Market share by Type, 2022
Fig 185: Indonesia Market share by Dialysis, 2022
Fig 186: Indonesia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 187: Indonesia Market Share by End User, 2022
Fig 188: Thailand Market share by Type, 2022
Fig 189: Thailand Market share by Dialysis, 2022
Fig 190: Thailand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 191: Thailand Market Share by End User, 2022
Fig 192: Brazil Market share by Type, 2022
Fig 193: Brazil Market share by Dialysis, 2022
Fig 194: Brazil Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 195: Brazil Market Share by End User, 2022
Fig 196: Mexico Market share by Type, 2022
Fig 197: Mexico Market share by Dialysis, 2022
Fig 198: Mexico Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 199: Mexico Market Share by End User, 2022
Fig 200: Turkey Market share by Type, 2022
Fig 201: Turkey Market share by Dialysis, 2022
Fig 202: Turkey Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 203: Turkey Market Share by End User, 2022
Fig 204: GCC Countries Market share by Type, 2022
Fig 205: GCC Countries Market share by Dialysis, 2022
Fig 206: GCC Countries Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 207: GCC Countries Market Share by End User, 2022
Fig 208: South Africa Market share by Type, 2022
Fig 209: South Africa Market share by Dialysis, 2022
Fig 210: South Africa Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 211: South Africa Market Share by End User, 2022
Fig 212: Australia Market share by Type, 2022
Fig 213: Australia Market share by Dialysis, 2022
Fig 214: Australia Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 215: Australia Market Share by End User, 2022
Fig 216: New Zealand Market share by Type, 2022
Fig 217: New Zealand Market share by Dialysis, 2022
Fig 218: New Zealand Market Value (US$ Mn) and Forecast 2023 to 2033
Fig 219: New Zealand Market Share by End User, 2022
- FAQs -
What is the value of the artificial kidney market in 2023?
The global artificial kidney market is valued at US$ 1.5 billion in 2023.
What is the estimated value of the artificial kidney market for 2033?
Worldwide sales of artificial kidneys are expected to reach US$ 5.3 billion by 2033.
At what rate is the artificial kidney market expected to increase during the forecast period?
Demand for artificial kidneys is set to increase rapidly at a CAGR of 13% from 2023 to 2033.
What is the primary reason for the growth of the market for artificial kidneys?
Rising prevalence of kidney-related disorders is driving the sales of artificial kidneys.
Why is North America a dominant regional market in this space?
North America holds a leading position in the global market due to the presence of key companies manufacturing artificial kidneys.
Related Reports
Artificial Kidney Market